Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A report from the Children's Oncology Group (ANBL0621)
Document Type
Journal Article
Publication Date
6-2014
Journal
Pediatric Blood and Cancer
Volume
Volume 61, Issue 6
Inclusive Pages
990-996
APA Citation
Fox, E., Mosse, Y.P., Meany, H.M., Gurney, J.G., Khanna, G. et al. (2014). Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A report from the Children's Oncology Group (ANBL0621). Pediatric Blood and Cancer, 61(6), 990-996.
Peer Reviewed
1
COinS